Emmaus Life Sciences, Inc. (EMMA) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $4.94 million versus the consensus estimate of $6 million.
Emmaus Life Sciences, Inc. (EMMA) reported Q3 EPS of ($0.01), $0.02 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $4.94 million versus the consensus estimate of $6 million.